International Standards of Corporate Social Responsibility

The article deals with internationally acknowledged standards and norms in the sphere of corporate social responsibility. It introduces the concept of social responsibility, the so-called triple-bottom line, in terms of which the company focuses not only on the economic growth but it also takes into account environmental and social aspects of its business activities. The article presents five norms and standards which stem from the triplebottom line concept. The norms and standards are in the article briefly characterised, which is followed by their comparison based on four previously stated criteria. The results of the comparison show that there is no such norm which would meet current company requirements. This paper resulted from contribution to a research project IGA FEM CULS 201011140057 "Modern Management Approaches in the Field of Higher Education in the Czech Republic"Corporate social responsibility, triple-bottom line, international standards and norms Anotace, Institutional and Behavioral Economics, GA, IN,

POSSIBILITIES OF USING UNCONVENTIONAL METHODS AND DIETARY SUPPLEMENTS TO AFFECT WEIGHT GAINS OF CALVES

Healthy and strong individuals are fundamental in every cattle breeding. The aim of this study was to find out which of these given supplement had the best influence on calf weight gain in the early period after weaning to milk nutrition. This research was carried out in cooperation with the farm in. Calves were studied from March 2012 to February 2013. They were weaned into outdoor individual box after birth. There were added supplements into their ration in the first two weeks of life. Calves were partitioned according to the added supplement into three experimental groups and one control group. The first weight control of calves was after birth and the second weight control was at the age of thirty days. The average weight gain was calculated from the differences in these values. The best demonstrable effect was in the experimental groups with the average increment of 26.9 kilograms, then in the experimental group with the average increment of 26.1 kilograms. The last group was the Control one, there was not any change in the ration and their average increment was 23.5 kilograms. The results of the statistical evaluation was p = 0.0572 in the group, p = 0.2570 in the group and p = 0.2124 in the group versus the Control group. It can be concluded from the results of this study that calves had a positive reaction on the supplements added in the first days of life and these had a favourable effect on diarrhoea prevention. drugs and beneficially stimulate system and, in general, they have a positive effect on the physiological condition

International Standards of Corporate Social Responsibility

The article deals with internationally acknowledged standards and norms in the sphere of corporate social responsibility. It introduces the concept of social responsibility, the so-called triple-bottom line, in terms of which the company focuses not only on the economic growth but it also takes into account environmental and social aspects of its business activities. The article presents five norms and standards which stem from the triplebottom line concept. The norms and standards are in the article briefly characterised, which is followed by their comparison based on four previously stated criteria. The results of the comparison show that there is no such norm which would meet current company requirements. This paper resulted from contribution to a research project IGA FEM CULS 201011140057 "Modern Management Approaches in the Field of Higher Education in the Czech Republic

Annual report: the Czech Republic 2008 drug situation.

Commissioned each year by the EMCCDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in each EU Member State. These data are key information to the EMCCDA and are an important resource, among others, for the compilation of its Annual report

Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor

Nucleophosmin (NPM1, B23) is a multifunctional phosphoprotein expressed in all tissues. The protein is mainly localized in nucleoli. In hematological malignancies, NPM1 belongs to commonly altered genes. Its mutation, always heterozygous, leads to the re-localization of the NPM1 protein from the nucleolus to the cytoplasm (NPM1c+). NPM1c+ is found in 30% of acute myeloid leukemia (AML). Our study showed that an AML patient, whose leukemia cells carried the NPM1c+ mutation and who was the recipient of allogeneic HSCT from a haploidentical donor, raised a robust allorestricted CD8+ T cell response directed against the NPM1wt protein. Favourably, the response against NPM1wt was not accompanied by side effects such as GvHD. Moreover, the induction of a high NPM1wt-specific response coincided with the decrease in NPM1c+ transcripts detected, implying a beneficial graft versus leukemia effect. On the basis of these results, we suppose that TCRs from allorestricted NPM1wt-specific T cells are worth studying in other recipients of grafts from haploidentical donors as a possible tool for TCR gene therapy

Unique Gene Expression Signatures in the Intestinal Mucosa and Organoids Derived from Germ-Free and Monoassociated Mice

Commensal microbiota contribute to gut homeostasis by inducing transcription of mucosal genes. Analysis of the impact of various microbiota on intestinal tissue provides an important insight into the function of this organ. We used cDNA microarrays to determine the gene expression signature of mucosa isolated from the small intestine and colon of germ-free (GF) mice and animals monoassociated with two E. coli strains. The results were compared to the expression data obtained in conventionally reared (CR) mice. In addition, we analyzed gene expression in colon organoids derived from CR, GF, and monoassociated animals. The analysis revealed that the complete absence of intestinal microbiota mainly affected the mucosal immune system, which was not restored upon monoassociation. The most important expression changes observed in the colon mucosa indicated alterations in adipose tissue and lipid metabolism. In the comparison of differentially expressed genes in the mucosa or organoids obtained from GF and CR mice, only six genes were common for both types of samples. The results show that the increased expression of the angiopoietin-like 4 (Angptl4) gene encoding a secreted regulator of lipid metabolism indicates the GF status

Analysis of chronic myeloid leukemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

This work investigated patient-specific genomic BCR-ABL1 fusions as markers of measurable residual disease (MRD) in chronic myeloid leukaemia, with a focus on relevance to treatment-free remission (TFR) after achievement of deep molecular response (DMR) on tyrosine kinase inhibitor (TKI) therapy. DNA and mRNA BCR-ABL1 measurements by qPCR were compared in 2189 samples (129 patients) and by digital PCR in 1279 sample (62 patients). A high correlation was found at levels of disease above MR4, but there was a poor correlation for samples during DMR. A combination of DNA and RNA MRD measurements resulted in a better prediction of molecular relapse-free survival (MRFS) after TKI stop (n = 17) or scheduled interruption (n = 25). At 18 months after treatment cessation, patients with stopped or interrupted TKI therapy who were DNA negative/RNA negative during DMR maintenance (green group) had an MRFS of 80% and 100%, respectively, compared with those who were DNA positive/RNA negative (MRFS = 57% and 67%, respectively; yellow group) or DNA positive/RNA positive (MRFS = 20% for both cohorts; red group). Thus, we propose a “traffic light” stratification as a TFR predictor based on DNA and mRNA BCR-ABL1 measurements during DMR maintenance before TKI cessation

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

Several studies have reported that chronic myeloid leukaemia (CML) patients expressing e14a2 BCR::ABL1 have a faster molecular response to therapy compared to patients expressing e13a2. To explore the reason for this difference we undertook a detailed technical comparison of the commonly used Europe Against Cancer (EAC) BCR::ABL1 reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) assay in European Treatment and Outcome Study (EUTOS) reference laboratories (n = 10). We found the amplification ratio of the e13a2 amplicon was 38% greater than e14a2 (p = 0.015), and the amplification efficiency was 2% greater (P = 0.17). This subtle difference led to measurable transcript-type dependent variation in estimates of residual disease which could be corrected by (i) taking the qPCR amplification efficiency into account, (ii) using alternative RT-qPCR approaches or (iii) droplet digital PCR (ddPCR), a technique which is relatively insensitive to differences in amplification kinetics. In CML patients, higher levels of BCR::ABL1/GUSB were identified at diagnosis for patients expressing e13a2 (n = 67) compared to e14a2 (n = 78) when analysed by RT-qPCR (P = 0.0005) but not ddPCR (P = 0.5). These data indicate that widely used RT-qPCR assays result in subtly different estimates of disease depending on BCR::ABL1 transcript type; these differences are small but may need to be considered for optimal patient management